JENBURKT PHARMACEUTICALS
Back to Income Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹137 Cr | ₹124 Cr | ₹109 Cr | ₹119 Cr | ₹123 Cr |
What is the latest Revenue of JENBURKT PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹137 Cr |
Mar2023 | ₹124 Cr |
Mar2022 | ₹109 Cr |
Mar2021 | ₹119 Cr |
Mar2020 | ₹123 Cr |
How is Revenue of JENBURKT PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹137 Cr | 10.30 | |
Mar2023 | ₹124 Cr | 13.44 | |
Mar2022 | ₹109 Cr | -8.07 | |
Mar2021 | ₹119 Cr | -3.06 | |
Mar2020 | ₹123 Cr | - |
Compare Revenue of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹533.3 Cr | -2.5% | -0.1% | 41.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -2.5% |
-0.1% |
41.8% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses